This large pharmaceutical company was facing the following challenges: - Solidify the network as the infrastructure across which their intellectual property is developed, quality-assured and delivered to market while enhancing global network security, speed and agility. - Better manage the process of merging acquired companies into the main corporate network. - Reduce business risk by implementing role-based access, full change tracking and the replacement of fragmented, spreadsheet-based management of IPAM data. - Increase the ROI on network-associated IT investments, such as virtualization, cloud and SDN.